Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 961–975 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3155 Sphingolipidosis Panel 3 Test This test quantifies the activity of three key lysosomal enzymes (acid sphingomyelinase, glucocerebrosidase, alpha-galactosidase A) to diagnose Gaucher, Niemann–Pick, and Fabry dis...	Whole Blood	4 working days	900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Acid Sphingomyelinase Activity", "Glucocerebrosidase Activity", "Alpha-Galactosidase A Activity"] Parameters [{"name": "Acid Sphingomyelinase", "reference_range": null}, {"name": "Glucocerebrosidase", "reference_range": null}, {"name": "Alpha-Galactosidase A", "reference_range": null}] Preparation ["Fasting is not required.", "Provide brief clinical history, complete list of current medications, and any prior relevant diagnoses."] Indications ["Suspected Gaucher disease", "Suspected Niemann-Pick disease (types A/B)", "Suspected Fabry disease"] Measurement technique Confirm with laboratory Codes LOINC: 54089-8 ICD-10: E75.22, E75.24, E75.21 Clinical summary This test quantifies the activity of three key lysosomal enzymes (acid sphingomyelinase, glucocerebrosidase, alpha-galactosidase A) to diagnose Gaucher, Niemann–Pick, and Fabry diseases.
TEST-3608 SPINK1 Gene Pancreatitis Next-Generation Sequencing (NGS) Genetic Test This genetic test evaluates the SPINK1 gene for pathogenic variants associated with hereditary pancreatitis and pancreatic cancer risk.	Standard Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPINK1 gene"] Parameters [] Preparation ["Do not discontinue prescribed medications without consulting your referring physician", "Avoid blood transfusions within two weeks prior to sample collection", "Inform your genetic counsellor about any recent illness or immunosuppressive therapy"] Indications ["Individuals with a family history of pancreatitis or pancreatic cancer", "Individuals with unexplained recurrent pancreatitis", "Individuals with early-onset pancreatitis without identifiable causes"] Measurement technique Confirm with laboratory Codes LOINC: 21674-2 ICD-10: K86.1 Clinical summary This genetic test evaluates the SPINK1 gene for pathogenic variants associated with hereditary pancreatitis and pancreatic cancer risk.
TEST-1093 Spinocerebellar Ataxia (SCA) Genetic Panel (Types 1, 2, 3, 6, 7, 10 & 12) Test This test identifies specific genetic mutations associated with Spinocerebellar Ataxia (SCA) subtypes 1, 2, 3, 6, 7, 10, and 12.	Peripheral Whole Blood	5-7 Business Days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Abnormal trinucleotide repeat expansions", "Specific SCA-associated genes (SCA1, SCA2, SCA3, SCA6, SCA7, SCA10, SCA12)"] Parameters [] Preparation ["No fasting required", "No special preparation needed"] Indications ["Clinical suspicion of hereditary ataxia", "Confirmation of SCA diagnosis", "Prognostic information", "Family planning and genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 86210-1 ICD-10: G11.0, Z13.71 Clinical summary This test identifies specific genetic mutations associated with Spinocerebellar Ataxia (SCA) subtypes 1, 2, 3, 6, 7, 10, and 12.
TEST-3075 Spinocerebellar Ataxia Type 3 (SCA3) ATXN3 Gene Mutation Analysis Test This diagnostic test evaluates the ATXN3 gene for CAG trinucleotide repeat expansions, which are the cause of Spinocerebellar Ataxia Type 3.	Whole blood	4–5 business days (sample collection Tuesday before 11 AM, report Saturday)	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansion in the ATXN3 gene", "Exact repeat length"] Parameters [{"name": "CAG Repeat Length", "reference_range": "Normal: Preparation ["No dietary restrictions are needed", "Complete the Genomics Clinical Information Requisition Form (Form 20)"] Indications ["Diagnosis confirmation for suspected SCA3", "Pre-symptomatic screening for at-risk individuals", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 21660-2 ICD-10: G11.2 Clinical summary This diagnostic test evaluates the ATXN3 gene for CAG trinucleotide repeat expansions, which are the cause of Spinocerebellar Ataxia Type 3.
TEST-4757 SPRED1 Gene Neurofibromatosis Type 1-Like Syndrome (Legius Syndrome) Genetic Test This genetic test analyzes the SPRED1 gene to identify pathogenic variants associated with Legius syndrome, a condition mimicking Neurofibromatosis Type 1.	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPRED1 gene", "Full coding sequence of SPRED1 gene (100% exons ±20 bp intronic boundaries)"] Parameters [{"name": "SPRED1 Gene Coverage", "reference_range": "100% exons ±20 bp intronic boundaries"}] Preparation ["No fasting required", "Provide complete clinical history and pedigree chart from pre-test genetic counselling session"] Indications ["Differential diagnosis between Neurofibromatosis Type 1 and Legius Syndrome", "Individuals with clinical features suggestive of NF1 but negative NF1 genetic testing", "Family members of individuals identified with a SPRED1 pathogenic variant"] Measurement technique Confirm with laboratory Codes LOINC: 95003-0 ICD-10: Q85.0 Clinical summary This genetic test analyzes the SPRED1 gene to identify pathogenic variants associated with Legius syndrome, a condition mimicking Neurofibromatosis Type 1.
TEST-1958 SPRED1 Gene Neurofibromatosis Type 1‑Like Syndrome (Legius Syndrome) Genetic Test This test evaluates the SPRED1 gene for variants associated with Legius syndrome, an NF1-like disorder.	Peripheral whole blood (EDTA tube or FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SPRED1 gene coding region variants", "Pathogenic variants associated with Legius syndrome"] Parameters [] Preparation [] Indications ["Diagnosis of Legius syndrome", "Evaluation of individuals with clinical features suggestive of Legius syndrome", "Genetic counseling for families with a history of Legius syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 77639-7 ICD-10: Q85.02, Z15.09, Z14.8 Clinical summary This test evaluates the SPRED1 gene for variants associated with Legius syndrome, an NF1-like disorder.
TEST-3342 SRP72 Gene Sequencing for Bone Marrow Failure Syndrome Type 1 Test This diagnostic test evaluates the SRP72 gene for pathogenic variants associated with autosomal recessive bone marrow failure syndrome type 1 (BMFS1).	Whole blood (3–5 mL in EDTA tube), Extracted DNA, or FTA card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SRP72 gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "Inform the laboratory if you have recently received a blood transfusion"] Indications ["Diagnosis of Bone Marrow Failure Syndrome Type 1 (BMFS1)", "Familial risk stratification for BMFS1"] Measurement technique Confirm with laboratory Codes LOINC: 101430-3 ICD-10: D61.09 Clinical summary This diagnostic test evaluates the SRP72 gene for pathogenic variants associated with autosomal recessive bone marrow failure syndrome type 1 (BMFS1).
TEST-3821 SS18L1 Gene Amyotrophic Lateral Sclerosis and CREST-Related Genetic Test This test identifies pathogenic variants within the SS18L1 gene associated with Amyotrophic Lateral Sclerosis (ALS) and CREST syndrome.	Whole Blood (Peripheral), Saliva, or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SS18L1 gene", "Copy Number Variations (CNV) in SS18L1"] Parameters [] Preparation ["No fasting required", "May continue regular medications"] Indications ["Diagnosis of ALS", "Diagnosis of CREST syndrome", "Risk assessment for ALS", "Risk assessment for CREST syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G12.21, M34.1 Clinical summary This test identifies pathogenic variants within the SS18L1 gene associated with Amyotrophic Lateral Sclerosis (ALS) and CREST syndrome.
TEST-4979 ST14 Gene Genetic Test for Autosomal Recessive Congenital Ichthyosis Type 11 (ARCI11) This diagnostic test evaluates the ST14 gene for variants associated with autosomal recessive congenital ichthyosis type 11 (ARCI11).	Whole Blood (EDTA) or Dried Blood Spot (FTA card)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ST14 gene coding exons", "ST14 gene splice junctions"] Parameters [] Preparation ["No fasting required", "Continue regular medication and skincare routine"] Indications ["Suspected diagnosis of ARCI11", "Family history of ARCI11", "Need for genetic counselling regarding ARCI11"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q80.8 Clinical summary This diagnostic test evaluates the ST14 gene for variants associated with autosomal recessive congenital ichthyosis type 11 (ARCI11).
TEST-6021 ST6GAL2 Gene Beta-Galactoside Alpha-2,6-Sialyltransferase 2 Deficiency Genetic Test This genetic test identifies pathogenic variants in the ST6GAL2 gene, confirming or ruling out Beta-Galactoside Alpha-2,6-Sialyltransferase 2 deficiency.	Whole blood (peripheral), extracted DNA, or FTA card spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ST6GAL2 gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected Beta-Galactoside Alpha-2,6-Sialyltransferase 2 deficiency", "Congenital disorder of glycosylation (CDG) investigation", "Family planning for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 94473-4 ICD-10: E77.8 Clinical summary This genetic test identifies pathogenic variants in the ST6GAL2 gene, confirming or ruling out Beta-Galactoside Alpha-2,6-Sialyltransferase 2 deficiency.
TEST-2510 STAC3 Gene Native American Myopathy Genetic Test This test detects pathogenic variants in the STAC3 gene associated with Native American myopathy.	Whole Blood or Buccal Swab	21 - 28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["STAC3 gene variants", "SNVs", "Small Indels", "Copy-Number Variants"] Parameters [] Preparation ["No fasting required", "Inform genetic team of anticoagulant therapy"] Indications ["Diagnosis of Native American myopathy", "Perioperative safety assessment", "Multidisciplinary care planning", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G71.2 Clinical summary This test detects pathogenic variants in the STAC3 gene associated with Native American myopathy.
TEST-4994 STAMBP Gene Microcephaly‑Capillary Malformation Syndrome NGS Test This test identifies pathogenic variants in the STAMBP gene associated with microcephaly‑capillary malformation syndrome.	Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Saliva (Oragene DNA Kit)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["STAMBP gene coding regions", "Pathogenic variants"] Parameters [] Preparation ["No special preparation such as fasting is required"] Indications ["Clinical suspicion of microcephaly‑capillary malformation syndrome", "Family history of the syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 92868-0 ICD-10: Q87.2 Clinical summary This test identifies pathogenic variants in the STAMBP gene associated with microcephaly‑capillary malformation syndrome.
TEST-3664 STAR Gene Lipoid Congenital Adrenal Hyperplasia Genetic Test This genetic test evaluates the STAR gene for pathogenic variants associated with Lipoid Congenital Adrenal Hyperplasia (LCAH). It identifies mutations causing adrenal insufficienc...	Whole Blood (Peripheral) or DNA Extract	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the STAR gene", "Copy Number Variations (CNV) in the STAR gene"] Parameters [] Preparation ["Genetic counseling is mandatory before testing", "Fasting is not required"] Indications ["Suspected Lipoid Congenital Adrenal Hyperplasia (LCAH)", "Neonatal screening for endocrine disorders", "Family history of LCAH", "Evaluation of adrenal insufficiency"] Measurement technique Confirm with laboratory Codes LOINC: 82377-1 ICD-10: E25.0 Clinical summary This genetic test evaluates the STAR gene for pathogenic variants associated with Lipoid Congenital Adrenal Hyperplasia (LCAH). It identifies mutations causing adrenal insufficiency and sex hormone deficiency.
TEST-5382 STAT1 Gene Atypical Mycobacterial Infection Genetic Test This genetic test analyzes the STAT1 gene for mutations associated with an increased risk of developing severe infections caused by atypical mycobacteria.	Peripheral blood (2 mL EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["STAT1 gene coding region variants", "STAT1 gene splice site variants", "STAT1 gene copy number variations"] Parameters [{"name": "STAT1 Gene Analysis", "reference_range": "No pathogenic variants detected"}] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Diagnosis of Mendelian susceptibility to mycobacterial disease (MSMD)", "Identification of STAT1 gene mutations in individuals with recurrent atypical mycobacterial infections", "Carrier screening in families with a known history of STAT1 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 100398-6 ICD-10: D84.8 Clinical summary This genetic test analyzes the STAT1 gene for mutations associated with an increased risk of developing severe infections caused by atypical mycobacteria.
TEST-5015 STAT3 Gene Hyper‑IgE Syndrome Genetic Test This test evaluates the STAT3 gene for pathogenic variants associated with Autosomal Dominant Hyper-IgE Syndrome (AD-HIES).	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["STAT3 gene sequence", "Pathogenic variants in STAT3"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Clinical suspicion of Autosomal Dominant Hyper-IgE Syndrome (AD-HIES)", "Recurrent infections", "Eczema", "Skeletal abnormalities"] Measurement technique Confirm with laboratory Codes LOINC: 101501-7 ICD-10: D82.4, Z15.89, Z82.79 Clinical summary This test evaluates the STAT3 gene for pathogenic variants associated with Autosomal Dominant Hyper-IgE Syndrome (AD-HIES).

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories